
Jiangsu Hualv Bio-Tech Co., Ltd.
Hualv
Jiangsu Hualv Bio-Tech Co., Ltd. is a Chinese industrialised mushroom grower listed on the ChiNext board of the Shenzhen Stock Exchange under code 300970. Founded in 2010, it is based in the Siyang Economic Development Zone in Suqian, Jiangsu Province, in one of the densest clusters of factory-scale mushroom production in the country. Its crop is grown indoors on fully automated computer-controlled lines rather than on open farmland: enoki mushrooms, beech mushrooms sold as white shimeji and as crab-flavour shimeji, and maitake. Jiangsu Hualv Bio-Tech is not a Fortune Global 500 company, and no company on that list owns it; revenue of RMB 1.292 billion in 2025 is about US$181 million, well under one per cent of the roughly US$32.2 billion threshold used for the 2025 list.
The company is young by the standards of this list. It appeared in 2010, at a moment when Chinese demand for enoki and beech mushrooms was moving from seasonal outdoor growing to year-round cultivation in climate-controlled rooms, and it has expanded by repeating a single plant design across provinces rather than by buying existing growers. Siyang in Jiangsu remains the base, and the group has since added Nanchuan in Chongqing, Wangdu in Hebei and sites in Guangxi, each placed close to the water, labour and agricultural by-products that industrialised cultivation consumes. Its ChiNext listing funded that build-out.
The range is narrow by design. Enoki is the volume line and the most exposed to the domestic price cycle, because Chinese enoki supply has grown faster than consumption in several recent years. Beech mushrooms, in white and brown forms including the crab-flavour type, carry a higher unit value and are sold both in consumer packs and in bulk to food service. Maitake is the smallest line and the closest to the premium end of the home market. Substrate is mixed in-house from agricultural by-products, filled into bottles, inoculated with spawn the group maintains itself and fruited in multi-tier rooms under tightly controlled temperature, humidity, light and carbon dioxide.
That method is repeated across six large intelligent production parks. Daily capacity is about 850 tonnes, or about 310,000 tonnes a year, and the group employs about 2,800 people. Six parks in a single country is a different shape from the multinational footprints of the Japanese and European growers on this list: each site is sized to its own region, and the two newest, in Chongqing and Hebei, were the main reason the 2025 results moved as they did.
Revenue in 2025 reached RMB 1.292 billion, an increase of 25.17% on the previous year, and net profit attributable to shareholders of the listed company doubled to RMB 110 million. China accounted for 98% of revenue, about RMB 1.27 billion of the total, so the improvement came from the ramp-up of new parks rather than from price. Brand heat in this study's assessment is 83 out of 100, reflecting a leading position in eastern and south-western China and a much weaker presence abroad.
The risk sits in the same numbers. With 98% of revenue earned at home and no overseas production to offset a domestic downturn, Hualv holds no hedge against the enoki and beech price swings that have punished Chinese growers whenever industry capacity arrives in a block. Its own expansion sharpens the exposure: the new parks carry fresh depreciation, so if wholesale mushroom prices fall while utilisation is still climbing, fixed cost per tonne rises exactly as the selling price falls. The company is growing into the price cycle rather than out of it.
Read More ▼Show Less ▲
Jiangsu Hualv Bio-Tech Co., Ltd. is a Chinese industrialised mushroom grower listed on the ChiNext board of the Shenzhen Stock Exchange under code 300970. Founded in 2010, it is based in the Siyang Economic Development Zone in Suqian, Jiangsu Province, in one of the densest clusters of factory-scale mushroom production in the country. Its crop is grown indoors on fully automated computer-controlled lines rather than on open farmland: enoki mushrooms, beech mushrooms sold as white shimeji and as crab-flavour shimeji, and maitake. Jiangsu Hualv Bio-Tech is not a Fortune Global 500 company, and no company on that list owns it; revenue of RMB 1.292 billion in 2025 is about US$181 million, well under one per cent of the roughly US$32.2 billion threshold used for the 2025 list.
The company is young by the standards of this list. It appeared in 2010, at a moment when Chinese demand for enoki and beech mushrooms was moving from seasonal outdoor growing to year-round cultivation in climate-controlled rooms, and it has expanded by repeating a single plant design across provinces rather than by buying existing growers. Siyang in Jiangsu remains the base, and the group has since added Nanchuan in Chongqing, Wangdu in Hebei and sites in Guangxi, each placed close to the water, labour and agricultural by-products that industrialised cultivation consumes. Its ChiNext listing funded that build-out.
The range is narrow by design. Enoki is the volume line and the most exposed to the domestic price cycle, because Chinese enoki supply has grown faster than consumption in several recent years. Beech mushrooms, in white and brown forms including the crab-flavour type, carry a higher unit value and are sold both in consumer packs and in bulk to food service. Maitake is the smallest line and the closest to the premium end of the home market. Substrate is mixed in-house from agricultural by-products, filled into bottles, inoculated with spawn the group maintains itself and fruited in multi-tier rooms under tightly controlled temperature, humidity, light and carbon dioxide.
That method is repeated across six large intelligent production parks. Daily capacity is about 850 tonnes, or about 310,000 tonnes a year, and the group employs about 2,800 people. Six parks in a single country is a different shape from the multinational footprints of the Japanese and European growers on this list: each site is sized to its own region, and the two newest, in Chongqing and Hebei, were the main reason the 2025 results moved as they did.
Revenue in 2025 reached RMB 1.292 billion, an increase of 25.17% on the previous year, and net profit attributable to shareholders of the listed company doubled to RMB 110 million. China accounted for 98% of revenue, about RMB 1.27 billion of the total, so the improvement came from the ramp-up of new parks rather than from price. Brand heat in this study's assessment is 83 out of 100, reflecting a leading position in eastern and south-western China and a much weaker presence abroad.
The risk sits in the same numbers. With 98% of revenue earned at home and no overseas production to offset a domestic downturn, Hualv holds no hedge against the enoki and beech price swings that have punished Chinese growers whenever industry capacity arrives in a block. Its own expansion sharpens the exposure: the new parks carry fresh depreciation, so if wholesale mushroom prices fall while utilisation is still climbing, fixed cost per tonne rises exactly as the selling price falls. The company is growing into the price cycle rather than out of it.
Business Nature
Core Business Areas
Industry Rankings
Corporate Report
VerityRank Score
Based on market presence, financial scale, operational capacity, and brand strength.
Quick Facts
Headquarters
No. 88 Renmin West Road, Siyang Economic Development Zone, Suqian, Jiangsu, China
Founded
2010
Employees
~2,800 (2025)
Revenue
RMB 1.292bn (~US$181m, 2025); net profit RMB 110m
Factories
6 intelligent mushroom production parks: Siyang, Nanchuan, Wangdu, Guangxi and others
Listing
Shenzhen Stock Exchange ChiNext: 300970
Categories
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website , Hualv Site · China Mushroom Sector · Market Trends · Edible Fungus Market · Market Size 2034 · Market Growth 2035
